Customer Poster by A. Pössl
Cell Therapy for the Treatment of Diabetes Mellitus: The Interplay between BioINK, Cell Culture and 3D-Printer
Our customer Axel Pössl, a Ph.D. student from the Institute of Bioprocess Engineering and Pharmaceutical Technology (IBPT) held a talk at the “European CELLINK Collaborative Partnership Conference” in June 2019 in Milan, Italy. He created a poster to visualize his talk below.
AimPössl’s work analyzes how using bioprinting in cell therapies can fulfill several goals, including higher and longer cell viability, long-term functionality of tissue, supportive structures for cells and reduced potential for immune rejection.
CELLINK products used
- CELLINK bioinks.
- CELLINK nozzles.
- Cell organization might be a key factor for highly viable and functional cell-laden structures.
- Physicochemical properties of bioink should mimic the in vivo extracellular matrix in humans.
- Critical printing process parameters are identified and established.